- Home
- RCKT vs CHPT Comparison
RCKT vs CHPT Comparison
Compare RCKT & CHPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKT
- CHPT
- Stock Information
- Founded
- RCKT 1999
- CHPT 2007
- Country
- RCKT United States
- CHPT United States
- Employees
- RCKT N/A
- CHPT N/A
- Industry
- RCKT Biotechnology: Pharmaceutical Preparations
- CHPT Industrial Specialties
- Sector
- RCKT Health Care
- CHPT Consumer Discretionary
- Exchange
- RCKT Nasdaq
- CHPT Nasdaq
- Market Cap
- RCKT 328.6M
- CHPT 340.1M
- IPO Year
- RCKT N/A
- CHPT N/A
- Fundamental
- Price
- RCKT $3.28
- CHPT $11.29
- Analyst Decision
- RCKT Buy
- CHPT Hold
- Analyst Count
- RCKT 13
- CHPT 10
- Target Price
- RCKT $12.96
- CHPT $29.13
- AVG Volume (30 Days)
- RCKT 6.0M
- CHPT 532.9K
- Earning Date
- RCKT 08-07-2025
- CHPT 09-03-2025
- Dividend Yield
- RCKT N/A
- CHPT N/A
- EPS Growth
- RCKT N/A
- CHPT N/A
- EPS
- RCKT N/A
- CHPT N/A
- Revenue
- RCKT N/A
- CHPT $407,681,000.00
- Revenue This Year
- RCKT N/A
- CHPT $2.79
- Revenue Next Year
- RCKT $108.43
- CHPT $24.20
- P/E Ratio
- RCKT N/A
- CHPT N/A
- Revenue Growth
- RCKT N/A
- CHPT N/A
- 52 Week Low
- RCKT $2.19
- CHPT $8.55
- 52 Week High
- RCKT $22.01
- CHPT $39.20
- Technical
- Relative Strength Index (RSI)
- RCKT 51.17
- CHPT 47.09
- Support Level
- RCKT $2.88
- CHPT $11.41
- Resistance Level
- RCKT $3.74
- CHPT $11.85
- Average True Range (ATR)
- RCKT 0.27
- CHPT 0.59
- MACD
- RCKT 0.02
- CHPT 0.08
- Stochastic Oscillator
- RCKT 35.43
- CHPT 39.55
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.
About CHPT ChargePoint Holdings Inc.
ChargePoint Holdings Inc designs, develops, and markets networked electric vehicle charging system infrastructure and cloud-based services that enable consumers to locate, reserve, and authenticate EV charging. The company's hardware product lineup includes solutions across home, commercial, and fast-charging applications. ChargePoint derives the majority of its revenue from the United States.